A detailed history of Madden Securities Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Madden Securities Corp holds 5,830 shares of CRL stock, worth $1.16 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
5,830
Previous 14,455 59.67%
Holding current value
$1.16 Million
Previous $2.99 Million 61.55%
% of portfolio
0.5%
Previous 1.34%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$187.96 - $245.29 $1.62 Million - $2.12 Million
-8,625 Reduced 59.67%
5,830 $1.15 Million
Q2 2024

Jul 10, 2024

SELL
$206.39 - $268.73 $252,827 - $329,194
-1,225 Reduced 7.81%
14,455 $2.99 Million
Q1 2024

Apr 09, 2024

SELL
$203.52 - $273.43 $156,710 - $210,541
-770 Reduced 4.68%
15,680 $4.25 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $385,305 - $559,363
-2,342 Reduced 12.46%
16,450 $3.89 Million
Q3 2023

Oct 10, 2023

SELL
$194.44 - $217.61 $159,051 - $178,004
-818 Reduced 4.17%
18,792 $3.68 Million
Q2 2023

Jul 06, 2023

SELL
$183.71 - $210.25 $209,613 - $239,895
-1,141 Reduced 5.5%
19,610 $4.12 Million
Q1 2023

Apr 21, 2023

BUY
$191.89 - $259.92 $320,456 - $434,066
1,670 Added 8.75%
20,751 $4.19 Million
Q4 2022

Jan 10, 2023

BUY
$197.11 - $250.07 $618,925 - $785,219
3,140 Added 19.7%
19,081 $0
Q3 2022

Oct 13, 2022

BUY
$182.44 - $250.54 $347,000 - $476,527
1,902 Added 13.55%
15,941 $3.14 Million
Q2 2022

Aug 04, 2022

BUY
$204.13 - $302.4 $1.17 Million - $1.73 Million
5,729 Added 68.94%
14,039 $3 Million
Q1 2022

Apr 28, 2022

BUY
$255.51 - $362.11 $1.39 Million - $1.97 Million
5,440 Added 189.55%
8,310 $2.36 Million
Q4 2021

Jan 14, 2022

SELL
$351.38 - $448.68 $14,055 - $17,947
-40 Reduced 1.37%
2,870 $1.08 Million
Q3 2021

Oct 14, 2021

SELL
$372.64 - $458.3 $1.15 Million - $1.41 Million
-3,085 Reduced 51.46%
2,910 $1.2 Million
Q2 2021

Jul 14, 2021

SELL
$294.17 - $371.65 $58,834 - $74,330
-200 Reduced 3.23%
5,995 $2.22 Million
Q1 2021

Apr 30, 2021

SELL
$249.67 - $299.48 $6,241 - $7,487
-25 Reduced 0.4%
6,195 $1.8 Million
Q4 2020

Jan 12, 2021

SELL
$222.0 - $252.62 $14,430 - $16,420
-65 Reduced 1.03%
6,220 $1.55 Million
Q3 2020

Oct 08, 2020

BUY
$175.56 - $226.45 $487,179 - $628,398
2,775 Added 79.06%
6,285 $1.42 Million
Q2 2020

Jul 14, 2020

BUY
$118.84 - $189.72 $59,182 - $94,480
498 Added 16.53%
3,510 $612,000
Q4 2019

Feb 25, 2020

BUY
$126.05 - $152.76 $379,662 - $460,113
3,012 New
3,012 $460,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Madden Securities Corp Portfolio

Follow Madden Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Madden Securities Corp with notifications on news.